Estimates of the health risks in humans from low-level exposure to tritium are presented.
The health risks considered are those for cancer, genetic effects, and developmental abnormalities from exposures in utero.
Because direct risk information for these effects is not available from human exposures to tritium, the following approach was used.
Excess risks for the effects given following low-level exposure to x rays or gamma rays were estimated from available human epidemiological data using appropriate dose-rate effectiveness factors.
These human-risk estimates for low-level x rays or gamma rays were then multiplied by the appropriate best-estimate relative biological effectiveness for tritium, taking into account differences in effectiveness of comparison radiations.
Mots-clés Pascal : Tritium, Analyse risque, Rayonnement gamma, Homme, Tumeur maligne, Dose faible, Développement, Maladie héréditaire
Mots-clés Pascal anglais : Tritium, Risk analysis, Gamma radiation, Human, Malignant tumor, Low dose, Development, Genetic disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0098761
Code Inist : 002B04E03. Création : 199406.